News and Press Releases

New Publication on LB Rhamnosus PB01

New Publication on LB Rhamnosus PB01 FOR IMMEDIATE RELASE. Copenhagen, Denmark, December 12th 2016 – Bifodan A/S is pleased to announce the publication of new and promising scientific evidence on its proprietary strain, Lactobacillus Rhamnosus PB01, and...

read more

Bifodan Scientific Advisory Board

Bifodan Scientific Advisory Board FOR IMMEDIATE RELASE. Copenhagen, Denmark / Massachusetts, USA, September 7th 2016 – Bifodan, manufacturer of private label probiotic finished solutions for the nutritional industry, is proud to present its newly...

read more

FastMelt Immuno

FastMelt Immuno FOR IMMEDIATE RELASE. Bifodan A/S Announces Release of FastMelt Immuno Copenhagen, Denmark, May 4th 2015 – Bifodan A/S, a distinct partner in probiotic finished solutions for the private label industry, announces the market introduction of...

read more

Ecovag®

Ecovag® Copenhagen, Denmark, January 14, 2015 – Bifodan A/S, the Danish based, - specialized provider of innovative probiotic solutions, - announces the establishment of a separate Business Unit for its Ecovag® probiotic activities targeting women’s...

read more

This site contains business-to-business information intended for business partners only. This site is not intended for the final consumer. It is neither to be used to market or advertise a product nor to make labelling claims. The statements contained herein are not evaluated as Health Claims by authorities. The statements herein have not been evaluated by the US Food and Drug Administration. The products contained herein are not intended to diagnose, cure or prevent any diseases. It is the sole responsibility of the company that markets the product to ensure that all national requirements are followed.

CONTROL REPORTS